Inspira Technologies Oxy B.H.N. Ltd. (IINN) has released an update.
Inspira Technologies Oxy B.H.N. Ltd., a medical technology innovator, has begun production of its INSPIRA ART100 device, a potentially less invasive respiratory treatment alternative to mechanical ventilation. The device, produced by a leading electronic assembly solutions provider, awaits U.S. FDA regulatory clearance before initial deployment. Inspira’s ART technology aims to allow patients to stay conscious during oxygenation treatment, offering a significant shift from traditional, riskier methods.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
